Toggle navigation
Home
Search
Services
Blog
Contact
About
Discovery of Antibodies to Neurotransmitter Receptors
Stinchcombe, Timothy
Tera Biotechnology Corporation, San Diego, CA, United States
Search 5 grants from Timothy Stinchcombe
Search grants from Tera Biotechnology Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Animal Hypoxia Core
Research Training in Environ &Occup Health in Southern*
Radiation Research Quantitative Methods and Models
Identifying Mitochondrial Import Components
Epidemiology of Main Neurological Disorders in China
Recently added grants:
Function of V-ATPases in Breast Cancer Metastasis
BLRD Research Career Scientist Award Application
Blrd Research Career Scientist Award Application
Strategic Molecular Activations for the Selective Synthesis of 2-Deoxy-Beta-Glycosides, and for the Synthesis of Novel Donor-Acceptor Stenhouse Adducts
A Dental implant registry of treatment outcomes of implant therapy by practitioners in the National Dental Practice Based Research Network
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43AA073008-002
Application #
2644372
Study Section
Project Start
1997-04-01
Project End
Budget Start
1997-08-26
Budget End
1997-09-30
Support Year
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Tera Biotechnology Corporation
Department
Type
DUNS #
959329814
City
San Diego
State
CA
Country
United States
Zip Code
92109
Related projects
NIH 1997
N43 AA
Discovery of Antibodies to Neurotransmitter Receptors
Stinchcombe, Timothy / Tera Biotechnology Corporation
NIH 1997
N43 AA
Discovery of Antibodies to Neurotransmitter Receptors
Stinchcombe, Timothy / Tera Biotechnology Corporation
Comments
Be the first to comment on Timothy Stinchcombe's grant